Walgreens Boots Alliance (WBA) Given New $82.00 Price Target at Loop Capital

Walgreens Boots Alliance (NASDAQ:WBA) had its price target lifted by Loop Capital from $80.00 to $82.00 in a research note published on Friday morning, The Fly reports. Loop Capital currently has a buy rating on the pharmacy operator’s stock.

WBA has been the subject of several other research reports. Zacks Investment Research raised shares of Walgreens Boots Alliance from a hold rating to a buy rating and set a $81.00 price target for the company in a research report on Tuesday, September 25th. ValuEngine raised shares of Walgreens Boots Alliance from a strong sell rating to a sell rating in a research report on Friday, September 21st. Robert W. Baird lifted their price target on shares of Walgreens Boots Alliance from $64.00 to $69.00 and gave the company a neutral rating in a research report on Tuesday, September 11th. Cowen downgraded shares of Walgreens Boots Alliance from an outperform rating to a market perform rating and set a $104.00 price target for the company. in a research report on Monday, July 23rd. Finally, BidaskClub raised shares of Walgreens Boots Alliance from a hold rating to a buy rating in a research report on Wednesday, September 12th. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating, seven have issued a buy rating and two have given a strong buy rating to the company. Walgreens Boots Alliance has a consensus rating of Hold and a consensus target price of $77.56.

Shares of WBA stock traded up $2.60 during trading hours on Friday, hitting $73.50. 9,645,179 shares of the company were exchanged, compared to its average volume of 6,227,956. The company has a market cap of $72.35 billion, a price-to-earnings ratio of 14.41, a price-to-earnings-growth ratio of 1.11 and a beta of 1.04. Walgreens Boots Alliance has a fifty-two week low of $59.07 and a fifty-two week high of $80.68. The company has a quick ratio of 0.47, a current ratio of 0.93 and a debt-to-equity ratio of 0.44.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, topping the consensus estimate of $1.45 by $0.03. The company had revenue of $33.44 billion during the quarter, compared to the consensus estimate of $33.64 billion. Walgreens Boots Alliance had a net margin of 3.36% and a return on equity of 21.22%. Analysts anticipate that Walgreens Boots Alliance will post 5.98 earnings per share for the current year.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Thursday, August 2nd. The stock was sold at an average price of $65.99, for a total transaction of $180,548.64. Following the transaction, the director now directly owns 10,943 shares in the company, valued at approximately $722,128.57. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Ornella Barra acquired 1,700,000 shares of the company’s stock in a transaction on Monday, July 16th. The shares were bought at an average price of $65.15 per share, for a total transaction of $110,755,000.00. The disclosure for this purchase can be found here. 14.80% of the stock is currently owned by company insiders.

Large investors have recently modified their holdings of the business. BlueMountain Capital Management LLC bought a new stake in shares of Walgreens Boots Alliance during the 2nd quarter worth $103,000. CSat Investment Advisory L.P. bought a new stake in shares of Walgreens Boots Alliance during the 2nd quarter worth $104,000. Squar Milner Financial Services LLC bought a new stake in shares of Walgreens Boots Alliance during the 2nd quarter worth $106,000. Kaizen Advisory LLC raised its stake in shares of Walgreens Boots Alliance by 128.6% during the 2nd quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock worth $116,000 after purchasing an additional 1,083 shares during the period. Finally, Livingston Group Asset Management CO operating as Southport Capital Management bought a new stake in shares of Walgreens Boots Alliance during the 3rd quarter worth $154,000. Institutional investors and hedge funds own 61.92% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Featured Article: Trading Strategy Methods and Types

The Fly

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply